Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease

Autor: Khan, Selina, Oosterhuis, Koen, Wunderlich, Kerstin, Bunnik, Evelien M., Bhaggoe, Melissa, Boedhoe, Satish, Karia, Santusha, Steenbergen, Renske D.M., Bosch, Leontien, Serroyen, Jan, Janssen, Sarah, Schuitemaker, Hanneke, Vellinga, Jort, Scheper, Gert, Zahn, Roland, Custers, Jerome

Publikováno v: International Journal of Cancer, 141(2), 393-404. Wiley-Liss Inc.
Khan, S, Oosterhuis, K, Wunderlich, K, Bunnik, E M, Bhaggoe, M, Boedhoe, S, Karia, S, Steenbergen, R D M, Bosch, L, Serroyen, J, Janssen, S, Schuitemaker, H, Vellinga, J, Scheper, G, Zahn, R & Custers, J 2017, ' Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16-and HPV18-induced infections and disease ', International Journal of Cancer, vol. 141, no. 2, pp. 393-404 . https://doi.org/10.1002/ijc.30679

High-risk Human papilloma virus (HPV) types are the causative agents of cervical cancer and several other anogenital malignancies. The viral proteins expressed in the (pre)malignant cells are considered ideal targets for immunological intervention. M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::98a6a5a33030c831adb4d3d9fee1f4d8
https://research.vumc.nl/en/publications/5304ea10-70cd-4b3a-942e-58fb042410d8